@aicri.bsky.social
Curious about what comes after your PhD or Postdoc?
🎟️ Register: bit.ly/4nKy9ld
Expect inspiring talks, real conversations about the research ecosystem, and insights from people who’ve taken unexpected paths.
🔗Agenda: bit.ly/4otE2Vb
@ucdresearch.bsky.social @irishmedicaltimes.bsky.social
Curious about what comes after your PhD or Postdoc?
🎟️ Register: bit.ly/4nKy9ld
Expect inspiring talks, real conversations about the research ecosystem, and insights from people who’ve taken unexpected paths.
🔗Agenda: bit.ly/4otE2Vb
@ucdresearch.bsky.social @irishmedicaltimes.bsky.social
The 2nd AICRIstart Symposium at Ulster University Belfast, was a fantastic gathering!
For a full overview, visit bit.ly/2ndAICRIstar....
Looking ahead to the 3rd AICRIstart Symposium, taking place at @cancerresearch-ucc.bsky.social @ucdresearch.bsky.social
The Breast Cancer Research Foundation - Debunking Common Myths About Triple-Negative Breast Cancer
@bcrfcure.bsky.social
oncodaily.com/blog/254371
#Cancer #BreastCancer #BreastCancerResearch #Medicine #Health #CancerResearch #Oncology #OncoDaily
The European Cancer Mission Hubs is featured on the cover of #EuroHealth by European Observatory on Health Systems and Policies! Prof. Arman Rahman & Prof. William Gallagher contributed an article on "Empowering Voices" (pg 31)
Read🔗https://bit.ly/EurohealthEmpoweringVoices
#CancerHasNoBorders
Up next to present at the 2nd #AICRIstart Symposium, PhD David Reck @tcddublin.bsky.social is identifying novel non-coding drivers that contribute to disease progression & therapeutic resistance.
#SharedIsland#NSRP
Pippa Blevings (Queens University Belfast)
Nano-engineered antigen formulations could enhance anti-tumor T-cell responses. #AICRIstart PhD Pippa Blevings is evaluating these approaches to optimise immunotherapy efficacy.
#AICRIstart #NSRP #SharedIsland
#CancerImmunotherapy #Nanomedicine
Sophie Carlin, a @ulsteruniversity.bsky.social PhD student is investigating epigenetic-targeted therapies for acute myeloid leukemia. As part of #AICRIstart, she is exploring synergistic drug combinations with albendazole to enhance treatment efficacy.
#SharedIsland #NSRP
Integrating chemical imaging & transcriptomic data, @AICRIstart PhD Mohd Rifaqi Rafsanjani from @wearetudublin.bsky.social is refining precision subtyping & recurrence prediction in colorectal cancer.
#ShareIsland #NSRP
Microproteins & long non-coding RNAs are emerging as potential biomarkers for ovarian cancer. #AICRIstart PhD student Abha Gupta @cancerresearch-ucc.bsky.social is investigating their role in tumor biology to improve early detection strategies supervision from Dr.Kellie Dean
#SharedIsland #NSRP
KRAS-driven lung cancer is notoriously aggressive. Our first speaker #AICRIstart PhD Saoirse Flanagan is tackling metabolic vulnerabilities to design targeted treatment options.
#LungCancer #TargetedTherapy
A great start to day 1 of the
2nd #AICRIstart Symposium @ulsteruniversity.bsky.social
Kicking off the #AICRIstart Symposim this morning @ulsteruniversity.bsky.social this morning @aicri.bsky.social
03.03.2025 13:00 — 👍 3 🔁 1 💬 0 📌 1
A group of National Challenge Fund researchers together for a photo
We welcomed #NationalChallengeFund teams and Skillnet Innovation Exchange to Three Park Place today for the first Discovery Exchange pitching event. As part Discovery Exchange, the teams have taken part in pitch training to hone their skills in communicating their ideas to varied audiences.
27.02.2025 16:34 — 👍 4 🔁 2 💬 0 📌 0
Excited to share our review on epigenetic reprogramming in brain metastasis. We review published studies on epigenetic drivers and outline future research directions we’re exploring: www.nature.com/articles/s41...
@breastcancernow.bsky.social @stefanprekovic.bsky.social @researchireland.bsky.social
Congratulations to AICRI Co-Lead Prof. William Gallagher on being Highly Commended in the Impact Award category at the @researchireland.bsky.social 2024 Researcher of the Year awards!
A well-deserved recognition of your consistent contributions to advancing cancer research.
